Brain injury marker rises with long seizures — act fast

Credibility

Interest

Key Takeaway

A blood and spinal fluid protein called NfL goes up mainly when seizures last a long time, showing that long seizures cause more brain injury regardless of seizure type.

What They Found

Researchers measured a protein called neurofilament light (NfL) in blood and spinal fluid from 28 patients who had status epilepticus, a long-lasting seizure emergency. NfL levels in blood and spinal fluid matched closely, so a simple blood test reflected what was in the spinal fluid. The main thing that raised NfL was how long the seizure lasted — the longer the seizure, the higher the NfL. NfL levels were similar whether seizures had big body jerks (convulsive) or did not (non-convulsive) once seizure length was considered. Higher NfL was not clearly linked to whether patients died, how hard the seizures were to treat, or standard outcome scores in this study.

Who Should Care and Why

People with MS and caregivers should care because seizures and their length can cause brain damage, and NfL is a measurable sign of that damage — like a smoke alarm that tells you how big a fire was. This means if someone with MS has a long seizure, doctors might use NfL (from a blood test) to see how much nerve damage happened, just like checking a thermometer after a fever. Caregivers and patients can use this to understand urgency: a long seizure is a true emergency whether it has shaking or not, similar to how both a small and large leak need quick attention. Neurologists and emergency teams may use NfL to help decide how aggressively to monitor brain injury after long seizures. For day-to-day life, the main practical point is to treat any prolonged seizure quickly — faster treatment likely means less nerve damage.

Important Considerations

This study looked at only 28 patients, so findings may not apply exactly to everyone with seizures or MS. The study cannot prove that high NfL causes worse long-term problems, only that it goes up with longer seizures — more research is needed to link NfL directly to recovery over time. Also, many things can raise NfL, so doctors will interpret levels alongside symptoms and other tests, not by NfL alone.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Specific Symptoms Early Research

Article Topics:

BiomarkerCerebrospinal fluid (CSF)NeurodestructionNeurofilament light (NfL)Status epilepticus (SE)

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News